Increasing evidence indicates the involvement of B cells in the pathogenesis of multiple
sclerosis (MS), but their precise roles are unclear. In this Review, we provide an overview of the …

The onset of multiple sclerosis (MS) in childhood poses diagnostic and therapeutic challenges,
particularly if the symptoms of the first demyelinating event resemble acute disseminated …

Abstract Treatment of multiple sclerosis (MS) is challenging: disease-modifying treatments (DMTs)
must both limit unwanted immune responses associated with disease initiation and …

B cells are not limited to producing protective antibodies; they also perform additional
functions relevant to both health and disease. However, the relative contribution of functionally …

Background B lymphocytes are implicated in the pathogenesis of multiple sclerosis. We
aimed to assess efficacy and safety of two dose regimens of the humanised anti-CD20 …

We evaluated the safety, tolerability, pharmacodynamics, and activity of B‐cell depletion with
rituximab in patients with relapsing‐remitting multiple sclerosis, receiving two courses of …

Matrix metalloproteinases (MMPs) are implicated in multiple sclerosis where one of their roles
may be to facilitate the transmigration of circulating leukocytes into the CNS. Studies have …

The emerging roles of microglia are currently being investigated in the healthy and
diseased brain with a growing interest in their diverse functions. In recent years, it has been …

… Bar-Or has served on scientific advisory boards for Biogen, F. Hoffmann-La Roche Ltd and
Genentech, Inc, GlaxoSmithKline plc, Guthy-Jackson/GGF, MedImmune, Merck/EMD Serono, …

Background There is increasing evidence that B lymphocytes are involved in the pathogenesis
of multiple sclerosis, and they may be a therapeutic target. Rituximab, a monoclonal …